Advancing Drug Development,
Shaping Korea's Future.

Korea Drug Development Fund (KDDF) is a national R&D initiative funded
by three government ministries. We support drug development across academia
and the pharmaceutical industry to advance innovative therapeutic pipelines.

Who We Are View Pipeline
Scroll to explore

KDDF Achievements at a Glance

2021-Present (as of August 2026)

0
Supported Pipelines
0
FDA/EMA Approvals
0
MFDS Approval
0
Licensing Deals
0
Orphan Drug Designations
0
IND Approvals

Pipeline Overview

Therapeutic Area

  • Oncology 51%
  • Immunology 11%
  • Neurology 9%
  • Metabolic 8%
  • Ophthalmology 7%
  • Respiratory 3%
  • Cardiovascular 2%
  • Gastrointestinal 0%
  • Others 9%

Modality

  • Small molecules 40%
  • Antibody 18%
  • Gene & Nucleic acids 13%
  • rProtein 11%
  • TPD 6%
  • Cell therapies 5%
  • RPT 1%
  • Others-Synth. 2%
  • Other-Bio. 4%
  • Botanic medicine 0%

Development Stage

  • Hit 18%
  • Lead 24%
  • Candidate 25%
  • Preclinical 21%
  • Phase 1 8%
  • Phase 2 4%
View full pipeline

Media Room

Photo, publications, news and video from KDDF.

Photo

More +
2026 KDDF Global Biotech Showcase (5/27~28, Fairmont Ambassador Seoul)
2026.06.02

Publication

More +
2026 KDDF Brochure
2026.03.05

News

More +
Nature Ad_Reshaping the future of drug discovery
2026.06.11

YouTube

More +
KDDF official channel
YouTube
Contact us
kddf@kddf.org | +82-2-6379-3050